Exelixis (EXEL) Non-Current Debt (2010 - 2016)

Exelixis (EXEL) recorded quarterly Non-Current Debt of $80.0 million in Q1 2016, little changed quarter-over-quarter from $80.0 million in Q4 2015, and little changed on a YoY basis from $80.0 million in Q2 2015.

Exelixis (EXEL) Non-Current Debt (2010 - 2016) Analysis & Trends

Exelixis' Non-Current Debt history runs 7 years deep, the most recent figure standing at $80.0 million for Q1 2016.

  • In Q1 2016, Non-Current Debt changed 0.0% year-over-year to $80.0 million; the TTM figure through Mar 2016 stood at $80.0 million (changed 0.0% YoY), while the FY2015 annual figure was $80.0 million, changed 0.0% from the prior year.
  • Non-Current Debt was $80.0 million for Q1 2016 at Exelixis, roughly flat from $80.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $84.5 million in Q1 2012 to a low of $80.0 million in Q3 2014.
  • Historically, Non-Current Debt has averaged $81.0 million across 5 years, with a median of $80.2 million in 2014.
  • The sharpest annual moves came in 2012 and 2015: Non-Current Debt fell 3.72% in 2012, then changed 0.0% in 2015.
  • A 5-year view of Non-Current Debt shows it stood at $82.1 million in 2012, then slipped by 2.15% to $80.3 million in 2013, then dropped by 0.41% to $80.0 million in 2014, then changed by 0.0% to $80.0 million in 2015, then changed by 0.0% to $80.0 million in 2016.
  • The last three Non-Current Debt figures came in at $80.0 million (Q1 2016), $80.0 million (Q4 2015), and $80.0 million (Q3 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2016 80.00 Mn
Mar 31, 2016 80.00 Mn
Dec 31, 2015 80.00 Mn
Dec 31, 2015 80.00 Mn
Sep 30, 2015 80.00 Mn
Sep 30, 2015 80.00 Mn
Jun 30, 2015 80.00 Mn
Jun 30, 2015 80.00 Mn
Mar 31, 2015 80.00 Mn
Mar 31, 2015 80.00 Mn
Dec 31, 2014 80.00 Mn
Dec 31, 2014 80.00 Mn
Sep 30, 2014 80.00 Mn
Sep 30, 2014 80.00 Mn
Jun 30, 2014 80.06 Mn
Jun 30, 2014 80.06 Mn
Mar 31, 2014 80.22 Mn
Mar 31, 2014 80.22 Mn
Dec 31, 2013 80.33 Mn
Dec 31, 2013 80.33 Mn